Showing results (71-80 of 77) with videos related to
Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 77 results.
ACS Medicinal Chemistry Letters|June 22, 2019
Discovery of a Lead Triphenylethanamine Cholesterol Ester Transfer Protein (CETP) InhibitorHeather J Finlay, Ji Jiang, Richard Rampulla, et al.Bioorganic & Medicinal Chemistry Letters|June 10, 2019
Identification of substituted benzothiazole sulfones as potent and selective inhibitors of endothelial lipaseSoong-Hoon Kim, James A Johnson, Ji Jiang, et al.Journal of Medicinal Chemistry|June 2, 2012
Diphenylpyridylethanamine (DPPE) derivatives as cholesteryl ester transfer protein (CETP) inhibitorsLalgudi S Harikrishnan, Heather J Finlay, Jennifer X Qiao, et al.Journal of Medicinal Chemistry|February 17, 2026
From Lead to Clinical Candidate: Discovery of BMS-986331 as a Potent and Selective N-Formyl Peptide Receptor 2 AgonistPravin S Shirude, Daniel Cheney, Amit K Chattopadhyay, et al.Bioorganic & Medicinal Chemistry Letters|February 12, 2014
Identification of 1-{2-[4-chloro-1'-(2,2-dimethylpropyl)-7-hydroxy-1,2-dihydrospiro[indole-3,4'-piperidine]-1-yl]phenyl}-3-{5-chloro-[1,3]thiazolo[5,4-b]pyridin-2-yl}urea, a potent, efficacious and orally bioavailable P2Y(1) antagonist as an antiplatelet agentYoon T Jeon, Wu Yang, Jennifer X Qiao, et al.Journal of Medicinal Chemistry|November 3, 2015
Triphenylethanamine Derivatives as Cholesteryl Ester Transfer Protein Inhibitors: Discovery of N-[(1R)-1-(3-Cyclopropoxy-4-fluorophenyl)-1-[3-fluoro-5-(1,1,2,2-tetrafluoroethoxy)phenyl]-2-phenylethyl]-4-fluoro-3-(trifluoromethyl)benzamide (BMS-795311)Jennifer X Qiao, Tammy C Wang, Leonard P Adam, et al.Journal of Medicinal Chemistry|February 18, 2022
Discovery of a Partial Glucokinase Activator Clinical Candidate: Diethyl ((3-(3-((5-(Azetidine-1-carbonyl)pyrazin-2-yl)oxy)-5-isopropoxybenzamido)-1H-pyrazol-1-yl)methyl)phosphonate (BMS-820132)Yan Shi, Ying Wang, Wei Meng, et al.Pageof 8